Marker Therapeutics, Inc. (MRKR)
2.19
+0.07
(+3.30%)
USD |
NASDAQ |
Jan 21, 16:00
2.18
-0.01
(-0.46%)
After-Hours: 20:00
Marker Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 70.00M |
| ADMA Biologics, Inc. | 137.67M |
| Kiniksa Pharmaceuticals International Plc | 51.74M |
| Neurocrine Biosciences, Inc. | 728.00M |
| AIM ImmunoTech, Inc. | -- |